Binary readability evaluation between chatbots. by Mete Kara (21568148)

Subjects:

Top 16 relevant keywords searched about Ankylosing spondylitis across countries: 2004-2023 (Based on Google trends data). by Mete Kara (21568148)

Subjects:

Overall CVD disease burden in DALYs attributable to 1^st-level risk factors in Chile. DALYs rates are expressed per 100,000 individuals, with a 95% uncertainty interval. by Camilo Briones-Valdivieso (21567535)

Subjects:

Prediction for the ecological functional composition of the bacterial community from Functional Annotation of Procaryotic Taxa (FAPROTAX) (A) and relationship between fertilization... by Qian Wang (32718)

Obese <i>mMgat2</i> and <i>HuMgat2</i> mice exhibit increased blood and liver lipid levels. by J. Jose Corbalan (22439198)

Subjects:

Obese <i>mMgat2</i> and <i>HuMgat2</i> mice have elevated Krebs cycle intermediate levels. by J. Jose Corbalan (22439198)

Subjects:

Obese <i>mMgat2</i> and <i>HuMgat2</i> mice show defects in solute transporter protein levels. by J. Jose Corbalan (22439198)

Subjects:

General characteristics of study subjects. by Soo-Hee Hwang (17767519)

“…COVID-19 did not affect inpatient mortality (p = 0.9608), but in-hospital mortality decreased from 12% to 7% in the medical aid group.</p><p>Conclusion</p><p>Overall, we found that COVID-19 had an impact on admission rates of patients with AMI but did not have a significant impact on in-hospital mortality. …”

Geometric mean anti-<i>Na</i>-GST-1 IgG subclass levels over time. by David J. Diemert (8135568)

Subjects:

Spatiotemporal pattern evolution of the health level of older adults in the Yangtze River Economic Belt. by Mengmeng Yang (475288)

Subjects:

Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

Subjects:

PIF4 protein level regulates <i>PIF4</i> promoter activity in a temperature-dependent manner. by Sreya Das (20531295)

Subjects:

Patient demographics. by Katrine Carlsen (5477300)

Subjects:

Association across weeks to treatment for three genera. by Katrine Carlsen (5477300)

Subjects:

Genera associated with FC, symptom score or week to treatment. by Katrine Carlsen (5477300)

Subjects:

Changes in alpha diversity in the weeks before anti-TNF-a treatment. by Katrine Carlsen (5477300)

Subjects:

Family clades associating with week to treatment, symptom score or FC. by Katrine Carlsen (5477300)

Subjects:

Alpha diversity measures across all 727 samples. by Katrine Carlsen (5477300)

Subjects:

Summary statistics for analysis of single genera clades. by Katrine Carlsen (5477300)

Subjects:

Abundance of the top 20 most abundant genera in one patient (Patient 1), across the weeks running up to treatment. by Katrine Carlsen (5477300)

Subjects: